Quarterly report pursuant to Section 13 or 15(d)

Capitalization and Equity Structure

v3.10.0.1
Capitalization and Equity Structure
6 Months Ended
Jun. 30, 2018
Stockholders' Equity Note [Abstract]  
Capitalization and Equity Structure
11.
Capitalization and Equity Structure
 
Summary
 
The Company’s authorized capital stock at June 30, 2018 consisted of 141,429 shares of common stock and 10,000 shares of preferred stock. At June 30, 2018, 60,832 shares of common stock were issued and outstanding and no shares of preferred stock were issued and outstanding.
 
Warrants
 
Warrant shares outstanding as of December 31, 2017 and June 30, 2018 were as follows:
  
Source
 
Exercise
Price
 
 
Term
(Years)
 
 
December 31,
2017
 
 
Issued
 
 
Expired
 
 
June 30, 2018
 
Information Agent Warrants
 
$ 1.50
 
 
 
3
 
 
 
200
 
 
 
-
 
 
 
-
 
 
 
200
 
2015 Warrants
 
$ 3.74
 
 
 
5
 
 
 
1,604
 
 
 
-
 
 
 
-
 
 
 
1,604
 
2014 PPO and Merger
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Placement agent warrants
 
$ 7.00
 
 
 
5
 
 
 
426
 
 
 
-
 
 
 
-
 
 
 
426
 
PPO warrants
 
$ 14.00
 
 
 
5
 
 
 
1,078
 
 
 
-
 
 
 
-
 
 
 
1,078
 
Pre-2014 warrants
 
$ 9.66
 
 
 
9-10
 
 
 
88
 
 
 
-
 
 
 
-
 
 
 
88
 
 
 
 
 
 
 
 
 
 
 
 
3,396
 
 
 
-
 
 
 
-
 
 
 
3,396
 
 
Information Agent Warrants
 
In September 2017, in connection with the Rights Offering in August 2017, the Company issued warrants to purchase 200 shares of the Company’s common stock with an exercise price of $1.50 per share to an information agent (the “Information Agent Warrants”). The Information Agent Warrants became exercisable immediately upon issuance. These warrants were recorded in stockholders’ equity on the Company’s condensed consolidated balance sheet.
 
2015 Warrants
 
In December 2015, the Company issued warrants to purchase 2,122 shares with an exercise price of $3.74 per share (the “2015 Warrants”). The 2015 Warrants contain a put-option provision. Under this provision, while the 2015 Warrants are outstanding, if the Company enters into a Fundamental Transaction, defined as a merger, consolidation or similar transaction, the Company or any successor entity will, at the option of each warrant holder, exercisable at any time within 30 days after the consummation of the Fundamental Transaction, purchase the warrant from the holder exercising such option by paying to the holder an amount of cash equal to the Black-Scholes value of the remaining unexercised portion of such holder’s warrant on the date of the consummation of the Fundamental Transaction. Because of this put-option provision, the 2015 Warrants are classified as a liability and are marked to market at each reporting date.
 
The warrant liability related to the 2015 Warrants is measured at fair value at each reporting date using certain estimated inputs, which are classified within Level 3 of the fair value hierarchy. The following assumptions were used in the Black Scholes Option Pricing Model to measure the fair value of the 2015 warrants as of June 30, 2018:
 
Current share price   $ 1.79  
Conversion price   $ 3.74  
Risk-free interest rate     2.57 %
Term (years)     2.5  
Volatility of stock     95 %